Status:
UNKNOWN
Telemonitoring Program in the Vulnerable Phase After Hospitalization for Heart Failure
Lead Sponsor:
Instituto Cardiovascular de Buenos Aires
Conditions:
Heart Failure
Acute Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This pragmatic clinical trial aims to evaluate the impact of a telemonitoring program with an electronic alert system compared to standard treatment on the perception of self-care in patients after ho...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Hospitalized for acute heart failure (regardless of the level of left ventricular ejection fraction) within 24 hours of discharge, or with a history of hospitalization for acute HF within 10 days prior to randomization.
- Own a smartphone (Smartphone) with internet Ability to speak and read Spanish.
- Residence in the metropolitan area of Buenos Aires
Exclusion
- Pregnancy
- Alcohol or drug abuse
- Kidney failure in hemodialysis,
- Inability to use the app (Ex: cognitive impairment, lack of social support, lack of ability to communicate)
- Active cancer
- Life expectancy less than 1 year
- Candidates for care home or institutional end of life
- Severe psychiatric illness
- Planned cardiac surgery
- Patient unable or unwilling to give informed consent to participate.
Key Trial Info
Start Date :
October 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 7 2023
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05972746
Start Date
October 7 2022
End Date
November 7 2023
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Cardiovascular de Buenos Aires
Buenos Aires, Buenos Aires F.D., Argentina, 1428